A detailed history of Alliancebernstein L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 50,502 shares of BHC stock, worth $386,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,502
Previous 50,502 -0.0%
Holding current value
$386,340
Previous $351,000 17.09%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.1 - $10.41 $16,775 - $28,627
-2,750 Reduced 5.16%
50,502 $351,000
Q1 2024

May 14, 2024

SELL
$7.77 - $10.61 $2,152 - $2,938
-277 Reduced 0.52%
53,252 $565,000
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $15,084 - $19,011
2,310 Added 4.51%
53,529 $429,000
Q3 2023

Nov 14, 2023

BUY
$7.69 - $9.71 $59,213 - $74,767
7,700 Added 17.69%
51,219 $421,000
Q2 2023

Aug 15, 2023

SELL
$5.72 - $8.8 $10,107 - $15,549
-1,767 Reduced 3.9%
43,519 $348,000
Q1 2023

May 15, 2023

SELL
$6.28 - $9.85 $44,902 - $70,427
-7,150 Reduced 13.64%
45,286 $366,000
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $166,671 - $217,028
27,368 Added 109.18%
52,436 $329,000
Q3 2022

Nov 15, 2022

SELL
$4.58 - $9.21 $3,173 - $6,382
-693 Reduced 2.69%
25,068 $173,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $23.63 $430 - $1,441
61 Added 0.24%
25,761 $215,000
Q1 2022

May 13, 2022

SELL
$21.6 - $27.79 $3.87 Million - $4.98 Million
-179,191 Reduced 87.46%
25,700 $587,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $4.12 Million - $5.2 Million
179,292 Added 700.39%
204,891 $5.66 Million
Q2 2021

Jul 30, 2021

SELL
$27.43 - $32.7 $68,684 - $81,880
-2,504 Reduced 8.91%
25,599 $751,000
Q1 2021

May 06, 2021

SELL
$21.37 - $34.38 $149,055 - $239,800
-6,975 Reduced 19.88%
28,103 $892,000
Q4 2020

Feb 08, 2021

BUY
$15.31 - $21.12 $918 - $1,267
60 Added 0.17%
35,078 $730,000
Q3 2020

Nov 12, 2020

SELL
$14.88 - $20.13 $286,395 - $387,442
-19,247 Reduced 35.47%
35,018 $544,000
Q2 2020

Aug 13, 2020

SELL
$13.31 - $20.51 $9,543 - $14,705
-717 Reduced 1.3%
54,265 $993,000
Q1 2020

May 14, 2020

BUY
$12.98 - $30.25 $287,247 - $669,432
22,130 Added 67.36%
54,982 $852,000
Q4 2019

Feb 18, 2020

SELL
$18.89 - $31.89 $151,592 - $255,917
-8,025 Reduced 19.63%
32,852 $983,000
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $7.58 Million - $9.32 Million
-363,114 Reduced 89.88%
40,877 $893,000
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $60,718 - $78,265
-2,959 Reduced 0.73%
403,991 $10.2 Million
Q1 2019

May 14, 2019

BUY
$20.23 - $26.29 $4.95 Million - $6.43 Million
244,649 Added 150.74%
406,950 $10.1 Million
Q4 2018

Feb 13, 2019

BUY
$17.64 - $28.32 $1.27 Million - $2.03 Million
71,715 Added 79.17%
162,301 $3 Million
Q3 2018

Nov 08, 2018

BUY
$20.64 - $25.67 $1.87 Million - $2.33 Million
90,586 New
90,586 $2.33 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.77B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.